Literature DB >> 12400562

The randomized controlled trial turns pro.

Jean-Louis Vincent.   

Abstract

Mesh：

Year:  2002        PMID： 12400562     DOI： 10.1007/s00134-002-1400-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 3.  Randomized, controlled clinical trials in sepsis: has methodological quality improved over time?

Authors:  Jürgen Graf; Gordon S Doig; Deborah J Cook; Jean-Louis Vincent; William J Sibbald
Journal:  Crit Care Med       Date:  2002-02       Impact factor: 7.598

4.  Quality of reporting of randomised controlled trials in the intensive care literature. A systematic analysis of papers published in Intensive Care Medicine over 26 years.

Authors:  Nicola Latronico; Marco Botteri; Cosetta Minelli; Cinzia Zanotti; Guido Bertolini; Andrea Candiani
Journal:  Intensive Care Med       Date:  2002-06-13       Impact factor: 17.440

5.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

6.  Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group.

Authors:  A Esteban; I Alía; M J Tobin; A Gil; F Gordo; I Vallverdú; L Blanch; A Bonet; A Vázquez; R de Pablo; A Torres; M A de La Cal; S Macías
Journal:  Am J Respir Crit Care Med       Date:  1999-02       Impact factor: 21.405

7.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

8.  International participation in major intensive care journals. "The smaller the better".

Authors:  M Shahla; A R Hedeshi; V Verhaeghe; J Gomez; J L Vincent
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

9.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  L Brochard; J Mancebo; M Wysocki; F Lofaso; G Conti; A Rauss; G Simonneau; S Benito; A Gasparetto; F Lemaire
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

10.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272
View more
  1 in total

1.  Generalisability of randomised controlled trials: a matter of discussion.

Authors:  Nicola Petrucci
Journal:  Intensive Care Med       Date:  2003-03-27       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.